AZN vs BVFL · P/E 28, $288.38B cap vs P/E 15, rev $49.7M
AstraZeneca PLC (AZN) versus BV Financial, Inc. Common Stock (BVFL) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
BV Financial, Inc. Common Stock (BVFL) is a banks - regional company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported BVFL revenue for 2025-12-31 was $49.7M. Net income was $13.5M. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. BVFL currently screens at market cap $167.8M and trailing P/E 15.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. BVFL currently screens at market cap $167.8M and trailing P/E 15.0.
Not investment advice. Open the AZN and BVFL stock pages for the full models.
Not investment advice.